Last reviewed · How we verify

NCT03128892

Oxygen Reserve Index Validation for RD Lite Sensors

Completed Results posted Last updated 1 March 2021
What this trial tests

trial testing Oxygen Reserve Index - RD Lite Sensors in Healthy in 34 participants. Completed in 29 March 2017.

Timeline
10 June 2016
Primary endpoint
29 March 2017
29 March 2017

Quick facts

Lead sponsorMasimo Corporation
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment34
Start date10 June 2016
Primary completion29 March 2017
Estimated completion29 March 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Masimo Corporation — full company profile →

Who can join

Adults 18 to 50, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Specificity of ORI to Detect Drops in Oxygenation Primary · 1-5 hours per subject

A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Specificity, as measured in this outcome, is the probability of ORI not dropping when there is no drop in blood oxygen levels (desaturation).

PaO2 Threshold: 110 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors98.50
PaO2 Threshold: 120 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors96.68
PaO2 Threshold: 130 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors98.89
PaO2 Threshold: 140 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors96.95
PaO2 Threshold: 150 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors97.67
PaO2 Threshold: 160 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors94.75
PaO2 Threshold: 170 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors93.60
PaO2 Threshold: 180 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors96.23
Sensitivity of ORI to Detect Drops in Oxygenation Primary · 1-5 hours

A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Sensitivity, as measured in this outcome, is the probability of ORI dropping when there is a drop in blood oxygenation levels (desaturation).

PaO2 Threshold: 110 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors84.96
PaO2 Threshold: 120 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors89.85
PaO2 Threshold: 130 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors85.51
PaO2 Threshold: 140 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors89.47
PaO2 Threshold: 150 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors86.17
PaO2 Threshold: 160 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors87.13
PaO2 Threshold: 170 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors83.96
PaO2 Threshold: 180 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors85.40
Concordance of ORI to Detect Drops in Oxygenation Primary · 1-5 hours

A measure of the ORI parameter's ability to detect changes in dissolved oxygen levels in blood plasma. Concordance, as measured in this outcome, is the probability of ORI to respond accurately to changes (or lack of thereof) in underlying blood oxygenation levels. It is computed as a ratio of true classifications (true positives and true negatives) to the sample size. An ideal detector will have a concordance value of 1 (or 100%).

PaO2 Threshold: 110 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors88.83
PaO2 Threshold: 120 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors92.46
PaO2 Threshold: 130 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors91.47
PaO2 Threshold: 140 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors93.33
PaO2 Threshold: 150 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors93.00
PaO2 Threshold: 160 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors92.16
PaO2 Threshold: 170 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors90.80
PaO2 Threshold: 180 mmHg
GroupValue95% CI
Oxygen Reserve Index (ORi) - RD Lite Sensors93.78

Adverse events — posted to ClinicalTrials.gov

Time frame: 1 to 5 hours. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Oxygen Reserve Index (ORi) - RD Lite Sensors
Serious: 0/34 (0%)
Deaths: 0/34
Other adverse events (1 terms — click to expand)

ReactionSystemOxygen Reserve Index (ORi)…
Arterial line site sensitivitySurgical and medical procedures

Data from ClinicalTrials.gov NCT03128892 adverse events section.

Sponsor's own description

Oxygen Reserve Index (ORI) is a parameter that provides information on arterial partial pressure of oxygen (PaO2). In this study, the PaO2 is varied by controlling the concentration of oxygen the study volunteer breathes. The ORI device measurement is analyzed by comparing it to the PaO2 measurements from a laboratory analyzer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Masimo Corporation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03128892.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing